HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Total body irradiation after high-dose cytarabine in mantle cell lymphoma: a comparison of Nordic MCL2, HOVON-45, and European MCL Younger trials.

AuthorsE Hoster, C H Geisler, J Doorduijn, B van der Holt, J Walewski, J Bloehdorn, V Ribrag, G Salles, M Hallek, C Pott, M Szymczyk, A Kolstad, A Laurell, R Räty, M Jerkeman, M Van't Veer, J C Kluin-Nelemans, W Klapper, M Unterhalt, M Dreyling, O Hermine
JournalLeukemia (Leukemia) Vol. 30 Issue 6 Pg. 1428-30 (06 2016) ISSN: 1476-5551 [Electronic] England
PMID26598017 (Publication Type: Comparative Study, Letter)
Chemical References
  • Antimetabolites, Antineoplastic
  • Cytarabine
Topics
  • Adult
  • Aged
  • Antimetabolites, Antineoplastic (administration & dosage, therapeutic use)
  • Chemoradiotherapy
  • Cytarabine (administration & dosage, therapeutic use)
  • Dose-Response Relationship, Drug
  • Humans
  • Lymphoma, Mantle-Cell (therapy)
  • Middle Aged
  • Stem Cell Transplantation
  • Whole-Body Irradiation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: